GAS8 Antisense Gene Protein 1 (GAS8-AS1)

[Edit]

C16orf3

GAS8 Antisense Gene Protein 1 (GAS8-AS1)
Loss of heterozygosity involving chromosome 16q24.3 is common in breast and prostate cancer and suggests the presence of a tumor suppressor gene. Whitmore et al. (1998) characterized a transcript located in the smallest region of deletion (GAS11). Within the second intron of the GAS11 gene, they discovered a second gene, C16ORF3 (chromosome 16 open reading frame 3), that is intronless, transcribed in the opposite orientation, and expressed at low levels. They performed mutational analysis by SSCA and could find no nucleotide base changes in either gene between 17 primary tumors and their corresponding matched normal DNA.25-kb GAS8 gene contains 11 exons separated by 10 introns. Intron 2 contains another gene, C16ORF3 (chromosome 16 open reading frame 3), which is intronless, transcribed in the opposite orientation, and expressed at low levels.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant GAS8 Antisense Gene Protein 1 (GAS8-AS1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to GAS8 Antisense Gene Protein 1 (GAS8-AS1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to GAS8 Antisense Gene Protein 1 (GAS8-AS1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for GAS8 Antisense Gene Protein 1 (GAS8-AS1) CLIA Kit Customized Service Offer
n/a ELISA Kit for GAS8 Antisense Gene Protein 1 (GAS8-AS1) ELISA Kit Customized Service Offer
  1. "Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer."Genomics 52:325-331(1998) [PubMed] [Europe PMC] [Abstract]
  2. "The sequence and analysis of duplication-rich human chromosome 16." Nature 432:988-994(2004) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]